Top Markets
#1 0G 0G +38.08%
#2 Axelar Axelar +22.24%
#3 Fake World Assets Fake World Assets +21.37%
#4 Bless Bless +19.68%
#5 Full Moon Full Moon +18.88%
#6 VVS Finance VVS Finance +18.18%
#7 Zora Zora +17.80%
#8 StonkBroker StonkBroker +16.79%
#9 Merlin's Seal BTC Merlin's Seal BTC +16.45%
#10 ADO Protocol ADO Protocol +15.64%
Coin of the day
0G 0G
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Hanx Biopharmaceuticals (Wuhan) Co., Ltd. Hanx Biopharmaceuticals (Wuhan) Co., Ltd.

Hanx Biopharmaceuticals (Wuhan) Co., Ltd.

3378
Kedudukan dalam Saham #13050
Hanx Biopharmaceuticals (Wuhan) Co., Ltd. engages in the research and... Hanx Biopharmaceuticals (Wuhan) Co., Ltd. engages in the research and development of immune-oncology therapies. The company's product pipeline includes HX009, a bifunctional anti-PD-1/SIRPa fusion protein that is in Phase IIa clinical trials for the treatment of EBV+ non-Hodgkin lymphoma, acral/mucosal subtype melanoma, relapsed/refractory melanoma post-PD-1 therapy, and Biliary tract cancer; HX044, a CTLA-4/SIRPa bifunctional fusion protein which is in Phase Ia for the treatment of solid tumours; HX301, a novel oral multi-kinase inhibitor that is in Phase IIa for the treatment of glioblastoma; and HX111, an ADC drug candidate to treat solid tumours. It is also developing proprietary in-house platforms, such as the VersatiBody, a multi-functional antibody discovery platform that generated two clinical-stage FIC bifunctional fusion proteins (HX009, HX044), as well as completed the preclinical development of multiple ADC/bispecific molecules, including FIC PPC HX111 (OX40-ADC) and HX116 (PD-L1×VEGF BsAb-ADC); and the autoRx40, an autoimmune therapeutic platform, completing the design of multiple candidate molecules in the field of autoimmune diseases, such as HX035, HX038, and HX138. Hanx Biopharmaceuticals (Wuhan) Co., Ltd. was incorporated in 2014 and is headquartered in Wuhan, China.
Harga Saham
$3.91
Modal Pasaran
$524.79M
Perubahan (1 hari)
-0.71%
Perubahan (1 tahun)
-
Negara
CN
Perdagangan Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378)

Kategori

Healthcare
Sejarah harga saham bagi Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378)
Harga penutupan tertinggi: $3.88 pada 2026-08-01

Harga penutupan terendah: $2.04 pada 2025-12-01
Sejarah harga saham Hanx Biopharmaceuticals (Wuhan) Co., Ltd. dari 2025 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 56.13%
2025 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.01 -13.08%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $752.76 6.28%
CH